These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15467035)

  • 1. Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma.
    Lindskog M; Spenger C; Jarvet J; Gräslund A; Kogner P
    J Natl Cancer Inst; 2004 Oct; 96(19):1457-66. PubMed ID: 15467035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose of arsenic trioxide inhibits multidrug resistant-related P-glycoprotein expression in human neuroblastoma cell line.
    Liu L; Li Y; Xiong X; Qi K; Zhang C; Fang J; Guo H
    Int J Oncol; 2016 Dec; 49(6):2319-2330. PubMed ID: 27840903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy in neuroblastoma: current status, prospects and limitations.
    Lindskog M; Spenger C; Klason T; Jarvet J; Gräslund A; Johnsen JI; Ponthan F; Douglas L; Nordell B; Kogner P
    Cancer Lett; 2005 Oct; 228(1-2):247-55. PubMed ID: 15946794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro.
    Piskareva O; Harvey H; Nolan J; Conlon R; Alcock L; Buckley P; Dowling P; Henry M; O'Sullivan F; Bray I; Stallings RL
    Cancer Lett; 2015 Aug; 364(2):142-55. PubMed ID: 25960282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (1H MRS).
    Lindskog M; Kogner P; Ponthan F; Schweinhardt P; Sandstedt B; Heiden T; Helms G; Spenger C
    Br J Cancer; 2003 Feb; 88(3):478-85. PubMed ID: 12569394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
    J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.
    Vassal G; Terrier-Lacombe MJ; Bissery MC; Vénuat AM; Gyergyay F; Bénard J; Morizet J; Boland I; Ardouin P; Bressac-de-Paillerets B; Gouyette A
    Br J Cancer; 1996 Aug; 74(4):537-45. PubMed ID: 8761367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivo.
    Ponthan F; Wickström M; Gleissman H; Fuskevåg OM; Segerström L; Sveinbjörnsson B; Redfern CP; Eksborg S; Kogner P; Johnsen JI
    Clin Cancer Res; 2007 Feb; 13(3):1036-44. PubMed ID: 17289900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of galectin-1 facilitated cisplatin sensitivity by inhibiting autophagy in neuroblastoma cells.
    Gao J; Wang W
    Chem Biol Interact; 2019 Jan; 297():50-56. PubMed ID: 30365942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential drug sensitivity of human neuroblastoma cells.
    Spengler BA; Ross RA; Biedler JL
    Cancer Treat Rep; 1986 Aug; 70(8):959-65. PubMed ID: 3731152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-resistance of topoisomerase I and II inhibitors in neuroblastoma cell lines.
    Keshelava N; Groshen S; Reynolds CP
    Cancer Chemother Pharmacol; 2000; 45(1):1-8. PubMed ID: 10647494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAIDs in neuroblastoma therapy.
    Johnsen JI; Lindskog M; Ponthan F; Pettersen I; Elfman L; Orrego A; Sveinbjörnsson B; Kogner P
    Cancer Lett; 2005 Oct; 228(1-2):195-201. PubMed ID: 15975708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.
    Keshelava N; Seeger RC; Groshen S; Reynolds CP
    Cancer Res; 1998 Dec; 58(23):5396-405. PubMed ID: 9850071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical study of treatment response in HCT-116 cells and xenografts with (1) H-decoupled (31) P MRS.
    Darpolor MM; Kennealey PT; Le HC; Zakian KL; Ackerstaff E; Rizwan A; Chen JH; Sambol EB; Schwartz GK; Singer S; Koutcher JA
    NMR Biomed; 2011 Nov; 24(9):1159-68. PubMed ID: 21994185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant neuroblastoma cells are responsive to arsenic trioxide at both normoxia and hypoxia.
    Karlsson J; Edsjö A; Påhlman S; Pettersson HM
    Mol Cancer Ther; 2005 Jul; 4(7):1128-35. PubMed ID: 16020671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of gamma-interferon with TRAIL and cisplatin or etoposide induces apoptosis in human neuroblastoma cell line SH-SY5Y.
    Tong HX; Lu CW; Zhang JH; Ma L; Zhang JH
    Chin Med Sci J; 2007 Mar; 22(1):38-43. PubMed ID: 17441316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
    Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of an in vitro model for cisplatin resistance in human neuroblastoma cell lines.
    Ireland CM; Pittman SM; Jones SL; Harnett PR
    Anticancer Res; 1994; 14(6B):2397-403. PubMed ID: 7872659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo.
    Johnsen JI; Lindskog M; Ponthan F; Pettersen I; Elfman L; Orrego A; Sveinbjörnsson B; Kogner P
    Cancer Res; 2004 Oct; 64(20):7210-5. PubMed ID: 15492235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.